Cardiac Extracellular Matrix Modification as a Therapeutic Approach

Area of Science:

• Biomaterials Science
• Cardiovascular Biology
• Tissue Engineering

Background:

• Cardiac extracellular matrix (cECM) provides structural and biochemical support to cardiovascular tissue.
• Integrins are cell surface receptors that interact with cECM proteins.
• In vivo models are limited in dissecting individual cECM protein effects due to tissue complexity.

Purpose of the Study:

• To track the evolution of understanding cECM's role in cell behavior.
• To explore the development of in vitro model systems for cECM research.
• To summarize how cECM basic studies inform its therapeutic applications.

Main Methods:

• Review of in vivo knockout animal models.
• Analysis of 2D in vitro model systems using tissue-derived cECM, recombinant proteins, and fragments.
• Examination of emerging 3D model systems, including 3D bioprinting.

Main Results:

• In vitro models offer greater control for dissecting cECM protein functions.
• Advancements include recombinant proteins, ECM mimics, and 3D bioprinting technologies.
• Basic research on cECM is informing its direct therapeutic use.

Conclusions:

• In vitro systems, particularly 3D models, are crucial for advancing cECM research.
• Understanding cECM's interaction with cells is key for developing new therapies.
• The evolution of models facilitates drug testing and scaffold generation.